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INTRODUCTION
Inflammation is a component of many common conditions encountered in pregnancy, including infection, preeclampsia and gestational diabetes (Slaviero et al., 2003) . The inflammatory response is associated with the induction of endogenous pro-inflammatory cytokines which impact gene regulation. Inflammation mediated either by vaccines, chemicals, cytokines or endotoxins has been shown to down-regulate several of the cytochrome P450 (CYP) isoforms (Morgan, 1997; Renton, 2001; Slaviero et al., 2003) .
In addition to drug metabolism, inflammatory responses also affect drug distribution and clearance through changes in drug transporters. Indeed, a downregulation in the expression and activity of several ATP-Binding Cassette (ABC) drug transporters, such as P-glycoprotein (Pgp or Mdr1) and the multidrug resistance-associated proteins (Mrp) have been reported in endotoxin, cytokine and turpentine models of inflammation (Piquette-Miller et al., 1998; Hartmann et al., 2001; Kalitsky-Szirtes et al., 2003) . It has only recently been recognized that the breast cancer resistance protein (Bcrp/Abcg2), a member of the ABC superfamily of transporters, also plays an important role in drug distribution and clearance. However, very little is known regarding the impact of inflammation on the in vivo expression of Bcrp.
Bcrp, originally discovered in breast cancer cells with a multidrug resistance phenotype, is thought to play an important protective role in normal tissues (Doyle and Ross, 2003) . Similar to other ABC transporters, Bcrp is a high capacity efflux transporter with a large variety of substrates, including anticancer and anti-retroviral drugs, toxins, endogenous nutrients, hormones and food additives (Staud and Pavek, 2005) . As Bcrp is highly expressed in placenta and is possibly involved in the placental transport of This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on May 27, 2008 as DOI: 10.1124 at ASPET Journals on June 22, 2017 dmd.aspetjournals.org Downloaded from numerous compounds, the regulation and activity of Bcrp could be of critical importance for fetal development and safety. It has been reported that glyburide, a sulfonylurea drug for treating hyperglycemia, is a substrate of Bcrp (Gedeon et al., 2006; Zhou et al., 2008) .
To date, more than 800 pregnant women have participated in clinical trials with glyburide and its usage as first-line therapy for gestational diabetes has been growing (Feig et al., 2007) . Fetal distribution of glyburide was recently shown to be significantly limited by Bcrp1 in mice (Zhou et al., 2008) . Other transporters such as the organic anion transporting polypeptides (Oatps), which belong to the solute carrier family, as well as Mrp3 have also been reported to interact with glyburide (Shitara et al., 2002; Gedeon et al., 2006) .
Therefore the primary objective of this study was to investigate the effect of endotoxin-induced inflammation on the placental expression of several key ABC drug efflux (Bcrp, Mdr1a, Mdr1b, Mrp1, Mrp2, and Mrp3) and solute carrier drug uptake (Oatp1a4, Oatp2b1, Oatp4a1) transporters in pregnant rats. A biodistribution study of glyburide was conducted in order to further investigate the impact of inflammation on placental drug transfer.
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MATERIALS AND METHODS
Animals and Experimental Design
All animal studies were approved by the University of Toronto Animal Care Committee (protocol number 
Determination of placental transporter mRNA expression
The mRNA levels of each transporter were examined by quantitative real time PCR.
Methods for RNA isolation, cDNA synthesis and real time PCR have been previously described (Goralski et al., 2003; Teng and Piquette-Miller, 2005; Wang et al., 2005) .
Briefly, RNA was extracted from tissues by use of the QuickPrep total RNA extraction kit (Amersham, Oakville, ON), and single-stranded complementary DNA (cDNA) was synthesized from 2.5 µg of RNA by use of the First Strand cDNA synthesis kit (MBI Fermentas, Burlington, ON) according to the manufacturer's protocol. Amplification DMD #19851 7 using real-time PCR was performed with the Roche Light Cycler (Roche, Laval, QC) using 25 ng of cDNA product and specific primers for each transporter (Table 1) 
Western blot analysis
Total membrane protein was isolated as previously reported (Hartmann et al., 2001; Wang et al., 2005 
Biodistribution of glyburide
Pregnant rats that had received 0.5 mg/kg endotoxin or saline (controls) 24 h earlier were used for the glyburide biodistribution study (n = 3-5 per group). Glyburide (24 µg/kg dissolved in ethanol and diluted in saline containing 25% DMSO; Sigma-Aldrich, St Louis, MO) was administered intravenously through the tail vein. Animals were sacrificed 1 h after glyburide administration. The 1 hour time period was chosen based on previous reports of glyburide biodistribution in pregnant rats and mice (Sivan et al., 1995; Zhou et al, 2008 
HPLC-UV Assay
Plasma and tissue glyburide concentrations were determined by a validated HPLC-UV assay (Gedeon et al, 2008 Standard calibration curves were constructed by adding glyburide to drug free plasma or tissue homogenates (600 µ L) to give final concentrations ranging from 0.025 to 0.500 µ g/mL. The detection sensitivity of this HPLC-UV assay was 4.2 ng/mL and 5.6 ng/g for plasma and tissue samples, respectively.
Immunohistochemistry
Placental tissues fixed in 4% PFA were paraffin-embedded and cut into 5 µ m sections.
Tissue sections were deparaffinized in xylene, and rehydrated. Endogenous peroxidase activity was blocked using 0. Network, Toronto, ON). After staining, the slides were visualized under a microscope and areas of interest recorded by a digital camera.
Measurement of Plasma Cytokine Levels
Maternal plasma cytokine levels of TNF-α and IL-6 were determined by using an enzyme-linked immunosorbent assay (ELISA) at 6 h and 24 h post-endotoxin administration. ELISA protocols for TNF-α (ABCam Laboratories, Cambridge, MA) and IL-6 (R&D Systems, Minneapolis, MN) were followed according to manufacturer's instructions. The samples were examined in duplicates and results within the standard curve range are reported. 
Data and Statistical Analysis
RESULTS
Effect of endotoxin on expression of ABC drug efflux transporters
We observed a significant dose-dependent downregulation in the mRNA levels of
Bcrp at 18 to 24 h in placentas obtained from endotoxin-treated rats (p < 0.05) ( Figure   1A ). A corresponding decrease in immunodetectable levels of Bcrp protein was seen in placentas isolated at 24 h ( Figure As depicted in Figure 3A , we observed a pronounced decrease in the placental mRNA expression of Mdr1a (Abcb1a) in the endotoxin-treated rats. A significant dose-and time-dependent downregulation was seen from 18 to 24 h post-endotoxin injection (p < 0.05). Endotoxin administration also imposed a significant decrease in mRNA levels of Mdr1b (Abcb1b) at 18 and 24 h ( Figure 3B ).
Significant decreases in the mRNA levels of Mrp1 (Abcc1), Mrp2 (Abcc2) and Mrp3 (Abcc3) were seen in the endotoxin-treated rats (Figure 4 ). Downregulation of Mrp1 mRNA was observed as early as 6 h post-endotoxin injection with a profound dose-and time-dependent effect seen at 24 h ( Figure 4A ). Decreases in mRNA levels of Mrp2
were seen between 12 to 24 h in the endotoxin-treated rats but this was only significant at This article has not been copyedited and formatted. The final version may differ from this version. 12 and 18 h ( Figure 4B ). Significant decreases in mRNA levels of Mrp3 were seen between 18 to 24 h in the endotoxin-treated rats ( Figure 4C ).
Effect of endotoxin on expression of Oatp drug transporters
As rat Oatp1a4 and human OATP2B1 have been reported to interact with glyburide, we also examined the impact of endotoxin on the expression of several Oatp isoforms.
The mRNA levels of the predominant isoforms of placental influx transporter Oatp, which include Oatp1a4 (Slco1a4; also known as Oatp2), Oatp2b1 (Slco2b1; also known as Oatp-B) and Oatp4a1 (Slco4a1; also known as Oatp-E) (Mikkaichi et al., 2004) were analyzed. In general, endotoxin-mediated reduction in mRNA levels of the Oatp isoforms occurred at earlier time points and recovered by 24 h post-endotoxin administration ( Figure 5 ). As compared to controls, Oatp1a4 mRNA was significantly reduced at 6 to 12 h in the endotoxin-treated rats ( Figure 5A ), whereas significant decreases in Oatp2b1 and Oatp4a1 mRNA were seen between 12 to 18 h (Figures 5B, 5C) (p < 0.05).
Effect of endotoxin on the biodistribution of glyburide
The biodistribution of glyburide was examined in order to assess the potential impact of inflammation-mediated changes in the expression of transporters on fetal drug exposure. While glyburide levels tended to be higher in control as compared to endotoxin-treated rats at 1 h post-administration, these differences did not reach statistical significance (control: 166 ± 48 ng/mL; endotoxin: 77 ± 13 ng/mL). However, a significant increase of glyburide accumulation was seen in fetuses of endotoxin-treated rats (162% of saline, p < 0.01). Normalizing fetal tissue glyburide levels to maternal plasma levels also revealed a 3.5 fold increase in the glyburide concentration ratio for fetuses obtained from endotoxin-treated rats as opposed to those from saline controls (p < 0.001) (Figure 6 ). While absolute amounts of glyburide accumulation (ng/g tissue) were significantly different only in the fetal tissue, normalized tissue:plasma levels of glyburide were significantly higher in maternal tissues obtained from endotoxin-treated rats. In the placenta, glyburide concentration ratio was 2.5 fold higher in endotoxintreated rats (p < 0.01), whereas the difference was 1.7 to 2.9 fold higher in maternal liver, intestine, kidney, and brain (p < 0.05) ( Figure 6 ). Plasma protein binding of glyburide was not significantly different between treatment groups (control: 80 ± 1.6%; endotoxin:
82 ± 1.6%).
Maternal plasma cytokine levels after endotoxin administration
In vivo administration of endotoxin is known to induce plasma levels of the proinflammatory cytokines. TNF-α and IL-6 are two of the major cytokines induced upon endotoxin administration in the circulation system of rodents. Our ELISA results demonstrated a dose-dependent 2-26 fold induction in maternal plasma TNF-α levels at 6 h post-endotoxin administration, with levels subsiding by 24 h (Table 2A) . At 6 hr, there was a pronounced 3-4 fold elevation in the plasma IL-6 levels of rats that received 0.5 -1.0 mg/kg of endotoxin (Table 2B) . By 24 h, plasma IL-6 levels decreased in rats treated with the lower endotoxin doses, but were dramatically elevated in the 1.0 mg/kg endotoxin treatment group (Table 2B) .
This article has not been copyedited and formatted. The final version may differ from this version. It has been previously demonstrated that endotoxin and other inflammatory stimuli impose a downregulation of Pgp in epithelial tissues of the liver, intestine, brain and placenta in rodents (Piquette-Miller et al., 1998; Hartmann et al., 2001; Goralski et al., 2003; Kalitsky-Szirtes et al., 2004; Wang et al., 2005) . Recently, it has been reported that intestinal expression of BCRP is decreased in patients with ulcerative colitis (Englund et al., 2007) , however the effect of inflammation on the placental Bcrp expression is unknown. Bcrp is highly expressed in the apical syncytiotrophoblast This article has not been copyedited and formatted. The final version may differ from this version. reported after exposure to tumor necrosis factor-alpha (TNF-α) or interleukin (IL)-1β (Evseenko et al., 2007) . Consistent with these in vitro findings, our results demonstrate a significant induction of TNF-α and IL-6 in the maternal plasma of endotoxin-treated rats.
This suggests that these cytokines could be involved as mediators of downregulation of placental Bcrp in endotoxin-treated rats.
Bcrp has been shown to restrict the passage of topotecan and mitoxantrone to the fetus in pregnant mice, thus it is believed that Bcrp plays an important role in the protection of fetus from exposure to toxic chemicals (Jonker et al., 2000) . In order to investigate the impact of endotoxin-mediated downregulation of transporter expression on fetal drug exposure we conducted a biodistribution study of glyburide, a sulphonylurea hypoglycemic agent that can be used to manage gestational diabetes. Glyburide has been shown to be actively transported by the human isoforms of BCRP and MRP3 but not PGP, MRP1 or MRP2 (Gedeon et al., 2006) . Furthermore, it has recently been shown that fetal distribution of glyburide is increased in Bcrp1 -/-pregnant mice as compared to wild-type controls (Zhou et al, 2008 (Zhou et al, 2008; Sivan et al, 1995) . Moreover, as concentrations of glyburide in fetal tissues decrease in parallel to maternal plasma concentrations after initial distribution, fetal:maternal plasma concentration ratios have been found to remain relatively constant between 1 to 4 hr after glyburide administration. Therefore it is probable that endotoxin-mediated changes in the fetal accumulation of glyburide are likely to persist at later time points. Glyburide concentrations were comparable to controls in maternal tissues, but when normalized to plasma levels, a significant increase in the ratio of tissue:plasma concentration was found in placental, liver, intestinal, kidney, and brain tissues of endotoxin-treated rats. Some of these changes could result, in part, due to Bcrp downregulation in maternal tissues, however changes in Bcrp alone cannot fully explain these findings. While alterations in plasma protein binding could result in an increased tissue distribution, we did not detect significant differences in glyburide protein binding in plasma obtained from endotoxin and control rats.
As evidence exists suggesting that glyburide uptake may occur through several of the Oatp transporters, it is plausible that inflammation-mediated changes in these transporters could contribute to alterations in glyburide uptake and distribution. Glyburide has been shown to be transported by human OATP2B1 (Satoh et al., 2005) and can inhibit transport activity of rat Oatp1a4 at high concentrations (Shitara et al., 2002) . There are several Oatp isoforms expressed in rat placenta, particularly Oatp2b1, Oatp4a1, and to a lesser extent Oatp1a4 (St-Pierre et al., 2004) . We detected significantly lower mRNA levels of all three isoforms in placental tissues obtained from endotoxin-treated rats.
Likewise, previous studies have reported an endotoxin-mediated downregulation of Oatp1a4 mRNA in the brain and liver of rodents (Hartmann et al., 2002; Goralski et al., 2003) . As a downregulation of the Oatp transporters would serve to decrease rather than increase the placental uptake and fetal accumulation of glyburide, it does not appear that 
FIG. 3. Effect of endotoxin on placental (A) Mdr1a and (B) Mdr1b mRNA levels in rats.
As described in methods, mRNA levels were determined by real-time PCR and normalized to Gapdh. Data represent the mean ± SEM as a percentage of control value (n=3-7/group). Statistics were calculated by ANOVA as described in methods. This article has not been copyedited and formatted. The final version may differ from this version. 
